Pharmaceuticals & Chemical Industries endorsed financial highlights for the five-month period that ended on November 30, showing that net profit fell 20% to EGP 4.5 million, from EGP 5.6 million reported in the same period a year earlier.
Financial results for the three-month period that ended on September 30, 2014 had mirrored EGP 2.26 million net profit, with a decline by 18% compared with EGP 2.76 million in the same period a year earlier.
Total revenues for the three-month period reached EGP 84.3 million, compared with EGP 97.4 million in Q1-13/14.
Financial results for the fiscal year that ended on June 30, 2014 had shown EGP 17 million net profit, with a decline by 23% compared with EGP 22.3 million a year earlier.
The company had generated EGP 12.9 million distributable net profit in the 11-month period till May 31, 2014, with a fall by 41% compared with EGP 22 million in the year-ago period.
Photo Credit: Arabianeye-Reuters